These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37441164)

  • 21. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot.
    Qiu Y; Patwa TH; Xu L; Shedden K; Misek DE; Tuck M; Jin G; Ruffin MT; Turgeon DK; Synal S; Bresalier R; Marcon N; Brenner DE; Lubman DM
    J Proteome Res; 2008 Apr; 7(4):1693-703. PubMed ID: 18311904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
    Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
    Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
    Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
    Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
    J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of stool microbiota, proteome and amino acid profiles to discriminate patients with adenomas and colorectal cancer.
    Bosch S; Acharjee A; Quraishi MN; Bijnsdorp IV; Rojas P; Bakkali A; Jansen EE; Stokkers P; Kuijvenhoven J; Pham TV; Beggs AD; Jimenez CR; Struys EA; Gkoutos GV; de Meij TG; de Boer NK
    Gut Microbes; 2022; 14(1):2139979. PubMed ID: 36369736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry.
    Zheng X; Xu K; Zhou B; Chen T; Huang Y; Li Q; Wen F; Ge W; Wang J; Yu S; Sun L; Zhu L; Liu W; Gao H; Yue L; Cai X; Zhang Q; Ruan G; Zhu T; Wu Z; Zhu Y; Shao Y; Guo T; Zheng S
    J Extracell Vesicles; 2020; 9(1):1750202. PubMed ID: 32363013
    [No Abstract]   [Full Text] [Related]  

  • 28. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
    Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction.
    Debernardi C; Libera L; Berrino E; Sahnane N; Chiaravalli AM; Laudi C; Berselli M; Sapino A; Sessa F; Venesio T; Furlan D
    Clin Epigenetics; 2021 Aug; 13(1):154. PubMed ID: 34372923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring.
    Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Abu Zaid M; Chiorean EG; Raftery D
    Anal Bioanal Chem; 2015 Oct; 407(26):7857-63. PubMed ID: 26342311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.
    Bosch LJW; de Wit M; Pham TV; Coupé VMH; Hiemstra AC; Piersma SR; Oudgenoeg G; Scheffer GL; Mongera S; Sive Droste JT; Oort FA; van Turenhout ST; Larbi IB; Louwagie J; van Criekinge W; van der Hulst RWM; Mulder CJJ; Carvalho B; Fijneman RJA; Jimenez CR; Meijer GA
    Ann Intern Med; 2017 Dec; 167(12):855-866. PubMed ID: 29159365
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Cervena K; Siskova A; Jungwirth J; Volarić M; Kral J; Kohout P; Levy M; Vymetalkova V
    Int J Gen Med; 2023; 16():3517-3531. PubMed ID: 37601809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.
    Deng L; Gu H; Zhu J; Nagana Gowda GA; Djukovic D; Chiorean EG; Raftery D
    Anal Chem; 2016 Aug; 88(16):7975-83. PubMed ID: 27437783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.
    Gu Y; Duan B; Sha J; Zhang R; Fan J; Xu X; Zhao H; Niu X; Geng Z; Gu J; Huang B; Ren S
    Int J Cancer; 2023 Feb; 152(3):536-547. PubMed ID: 36121650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson's Disease and Parkinsonian Syndromes Patients.
    Gątarek P; Kałużna-Czaplińska J; Pawełczyk M; Jastrzębski K; Giebułtowicz J; Głąbiński A; Bobrowska-Korczak B
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33120888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis.
    Qian S; Lin S; Xu X; Bai H; Yeerken A; Ying X; Li Z; Fei X; Yang J; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2022 Sep; 14(1):111. PubMed ID: 36064442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening.
    Meng W; Zhu HH; Xu ZF; Cai SR; Dong Q; Pan QR; Zheng S; Zhang SZ
    World J Gastrointest Oncol; 2012 Jun; 4(6):145-51. PubMed ID: 22737276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.